SCHEMBL12389152

SCHEMBL12389152

CCCCOC[C@H]1O[C@@H](c2ccc(C(N)=O)n2N)[C@](C)(OCCCC)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11924464 0.86 — —
SCHEMBL13696402 0.86 — —
SCHEMBL9912326 0.86 — —
SCHEMBL9912323 0.83 — —
SCHEMBL13696396 0.83 — —
SCHEMBL11924456 0.83 — —
SCHEMBL12365716 0.79 NT5E (0.35) —
SCHEMBL13392130 0.76 — —
SCHEMBL10100144 0.75 CSNK2A2 (0.33) —
SCHEMBL14141098 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994139-B2 Antiviral therapeutic agents BIOCRYST PHARMACEUTICALS, INC. (US) 2011-08-09 — — US disclosed
Send feedback